All News

Finance & Investment

Arcellx and Gilead’s Kite Further Expands Their Strategic Partnership
16 November 2023
Arcellx and Gilead’s Kite Further Expands Their Strategic Partnership
Kite has decided to exercise
The Fundamental Challenges and Strategies Biotech Start-Ups in the Cell and Gene Industry Should Consider
11 October 2023
The Fundamental Challenges and Strategies Biotech Start-Ups in the Cell and Gene Industry Should Consider
Bloomberg Intelligence's Ann-Hunter van Kirk
Proactive Strategies for Biotech Success in the 2024 Landscape
10 October 2023
Proactive Strategies for Biotech Success in the 2024 Landscape
Join us for a pragmatic
Examining Risk: Differing CGT Funding Strategies Within Europe, the USA & Asia
7 September 2023
Examining Risk: Differing CGT Funding Strategies Within Europe, the USA & Asia
Ann-Hunter van Kirk, Bloomsberg Intelligence,
POPULAR NEWS ITEMS
Image
4 December 2023

20 Years of Advanced Therapies with David McCall: a Retrospective on Phacilitate’s Founding and Evolution of the Industry

Image
6 December 2023

Oxford Biomedica Acquires ABL Europe from Institut Mérieux

Image
5 December 2023

Texas Children’s Hospital First to Deliver a Novel Gene Therapy for Rett Syndrome

LEXEO Therapeutics Attains Strategic Investment from Sarepta Therapeutics to Support LEXEO’s Cardiovascular Gene Therapies
29 August 2023
LEXEO Therapeutics Attains Strategic Investment from Sarepta Therapeutics to Support LEXEO’s Cardiovascular Gene Therapies
LEXEO Therapeutics attains strategic investment
Cellares Raises $255M Series C to Launch First Integrated Development and Manufacturing Organization
24 August 2023
Cellares Raises $255M Series C to Launch First Integrated Development and Manufacturing Organization
Cellares has secured $255 million
Precision BioSciences Completes Strategic $227M Transaction with Imugene for CAR-T Therapy
17 August 2023
Precision BioSciences Completes Strategic $227M Transaction with Imugene for CAR-T Therapy
Precision BioSciences Completes Strategic Transaction
Kyverna’s Series B Financing Round Extends to $145M
3 August 2023
Kyverna’s Series B Financing Round Extends to $145M
Kyverna Therapeutics has oversubscribed its
Load more News
RECOMENDED TOPICS
Clinical Trials
Collaborations, Mergers & Acquisitions
Finance & Investment
Patient Access & Engagement
Regulatory & Standards
Reimbursement
Strategy
POPULAR NEWS ITEMS
Image

20 Years of Advanced Therapies with David McCall: a Retrospective on Phacilitate’s Founding and Evolution of the Industry

Image

Oxford Biomedica Acquires ABL Europe from Institut Mérieux

Image

Texas Children’s Hospital First to Deliver a Novel Gene Therapy for Rett Syndrome